Fragmentation et défragmentation du droit des innovations biomédicales (I-BioLex)
Published January 18, 2023 | Version v1
Poster Open

Comparative quality aspects of Gene therapy medicinal products and medicinal products containing genetically modified cells

Authors/Creators

  • 1. Aix-Marseille Université, CNRS
  • 2. Aix-Marseille Université
  • 3. Hôpitaux de Marseille (AP-HM)
  • 4. University of Oxford

Description

Poster presented at the 2022 Conference of the European Association of Health Law (EAHL) in Ghent.

Notes

Also available : https://shs.hal.science/halshs-03779383v1

Files

EAHL 2022 - Comparative quality aspects GTMP et MPGMO.pdf

Files (4.5 MB)

Additional details

Funding

Agence Nationale de la Recherche
I-BioLex - Fragmentation and defragmentation of the law on biomedical innovations ANR-20-CE26-0007